Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Eli Lilly shares surged to fresh highs, underpinned by upbeat analyst notes and strong pipeline momentum. This guide ...
A little-known corner of the market, rare earth stocks have moved in big swings. Here's how USA Rare Earth powered an...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Delve into a comprehensive guide to understanding Gibraltar (Rock) 2026 earnings through the Q1 2026 transcript. Lear...
SolarEdge and Enphase surged as residential solar demand improved, while Canadian Solar slid, underscoring a sharp sp...
Bitcoin briefly moved under $74,000 as on-chain metrics signal fading momentum. Traders warn that the $75k zone may c...
A public rebuke of management sparks a wave of worker stories about the price of speaking up at work and how it affec...
A new investor suit alleges Zillow misled investors about its February 2025 Redfin rental listings deal, intensifying...